This inventor holds 3 USPTO granted patents. Top assignees: Korea Research Institute of Bioscience and Biotechnology, Korea Institute of Industrial Technology. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020-2026
Title: Phil Yong Kang: Innovator in B Cell Research
Introduction
Phil Yong Kang is a notable inventor based in Cheongju, South Korea. He has made significant contributions to the field of bioscience, particularly in the area of memory B cell differentiation. With a total of 3 patents, his work has implications for immunology and therapeutic applications.
Latest Patents
One of his latest patents is titled "Method for memory B cell-specific differentiation induction, and uses thereof." This invention relates to a method for inducing memory B cell-specific differentiation using an anti-CD3 antibody or ligand in a biological sample. It also includes a method for detecting memory B cells that are specific to a particular antigen. Another significant patent is "Dwarfism animal model having IGF-1 genetic mutation and method for producing same." These patents showcase his innovative approach to addressing complex biological challenges.
Career Highlights
Phil Yong Kang has worked with esteemed organizations such as the Korea Research Institute of Bioscience and Biotechnology and the Korea Institute of Industrial Technology. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Throughout his career, Phil has collaborated with notable colleagues, including Kyu Tae Chang and Kang Jin Jeong. These partnerships have enriched his research endeavors and fostered innovation in his field.
Conclusion
Phil Yong Kang is a distinguished inventor whose work in memory B cell research has the potential to impact therapeutic strategies in immunology. His patents reflect a commitment to advancing scientific knowledge and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile